Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›
Research›
Non-Profits›
Alzheimer's Drug Discovery Foundation
AddedFeb 15, 2024
UpdatedJun 28, 2026
Alzheimer's Drug Discovery Foundation

Alzheimer's Drug Discovery Foundation

Operating

ADDF, a nonprofit, funds global Alzheimer's research and clinical trials, investing $65M in 450+ programs.

Founded
1998
Location
New York City, NY, US
Overview
Compare
Employees
Website

The Alzheimer's Drug Discovery Foundation (ADDF) is a nonprofit organization founded in 1998 by Leonard A. Lauder and Ronald S. Lauder. Its core mission is to accelerate the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The ADDF focuses on funding early-stage research and early-phase clinical trials that might otherwise go unfunded. The organization supports a range of programs, including preclinical drug research, clinical trials, cognitive vitality and prevention, and ADDF Access, which aims to expedite the development of effective treatments.

Notable figures affiliated with ADDF include Dr. Howard Fillit, who serves as the Executive Director and Chief Science Officer. The foundation has invested over $65 million in more than 450 programs globally. Key achievements include funding groundbreaking studies published in prestigious journals like Nature Medicine and receiving endorsements from influential figures such as Bill Gates. The ADDF's impact is significant in the Alzheimer's research community, driving innovation and hope for new treatments.

Alzheimer's Drug Discovery Foundation - Quick Facts

When was Alzheimer's Drug Discovery Foundation founded?

Alzheimer's Drug Discovery Foundation was founded in 1998.

Where is Alzheimer's Drug Discovery Foundation's headquarters located?

Alzheimer's Drug Discovery Foundation's headquarters is located in New York City, NY, US.

How many employees does Alzheimer's Drug Discovery Foundation have?

Alzheimer's Drug Discovery Foundation has 70 employees as of Feb 4, 2024.

Alzheimer's Drug Discovery Foundation - Classification

Ownership
  • Non-profit
Technology
  • Biotech
Main Product
  • Drug Research
Tags
  • Geographic Region
  • Non-profit
NAICS
  • 621000Ambulatory Health Care Services
  • 621300Offices of Other Health Practitioners
  • 621330Offices of Mental Health Practitioners (except Physicians)
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 4772Retail sale of pharmaceutical and medical goods, cosmetic and toilet articles in specialized stores
Show 16 more industry codes
NAICS
  • 456000Health and Personal Care Retailers
  • 813000Religious, Grantmaking, Civic, Professional, and Similar Organizations
  • 813900Business, Professional, Labor, Political, and Similar Organizations
  • 813920Professional Organizations
  • 450000Retail Trade
  • 810000Other Services (except Public Administration)
  • 456100Health and Personal Care Retailers
  • 456110Pharmacies and Drug Retailers
SIC
  • 8600Membership Organizations
  • 8690Membership Organizations, Not Elsewhere Classified
  • 8733Noncommercial Research Organizations
  • 5900Miscellaneous Retail
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 5910Drug Stores And Proprietary Stores
  • 8730Research, Development, And Testing Services
  • 5912Drug Stores and Proprietary Stores